Speeches and presentations

Search through our archive of speeches and presentations from conferences and events.

Visit our corporate reporting archive for our Annual Reports.

For quarterly results materials visit quarterly results.

10 March 2011

Presentation to investors

Abbas Hussain, President, Emerging Markets, gave a presentation to a small group of investors, where he provided an overview of GSK's emerging markets strategy.

Abbas Hussain

08 March 2011

Cowen and Company 31st Annual Health Care Conference

Patrick Vallance, SVP – Medicines Discovery and Development, gave a presentation at the Cowen and Company 31st Annual Health Care Conference in Boston. Patrick provided an overview of GSK’s R&D Strategy and its Focus on Return on Investment.

Dr Patrick Vallance

21 February 2011

CED Biotech/Life Science Conference

Deirdre Connelly, President, North American Pharmaceuticals, addressed the CED Biotech/Life Science Conference in Raleigh, Durham, on 21 February 2011.

Deidre Connelly

10 February 2011

The Economist Pharma Summit

David Redfern, GSK Chief Strategy Officer, was one of the two keynote speakers at The Economist Pharma Summit Reinventing Pharma for a New Generation  on 10 February 2011 in London. He outlined GSK’s strategic priorities, our innovative approach to pricing and the value of our late stage pipeline coupled with our ongoing efforts to drive the effectiveness of R&D.

David Redfern

24 January 2011

CBI 8th Annual Pharmaceutical Compliance Conference

Deirdre Connelly, President, North American Pharmaceuticals, addressed the 8th annual Center for Business Intelligence (CBI) pharmaceutical compliance conference on 24 January. Deirdre spoke about what the pharmaceutical industry must do to build trust.

Deidre Connelly

12 January 2011

JP Morgan Healthcare Conference

David Redfern, Chief Strategy Officer at GlaxoSmithKline, gave a presentation at the 29th Annual JP Morgan Healthcare Conference in San Francisco.  David provided an overview of the progress being made in implementing GSK’s strategy.

David Redfern

09 December 2010

CEO Andrew Witty discusses R&D and drug discovery on BBC Radio 4

CEO Andrew Witty discusses R&D and drug discovery on BBC Radio 4.

Sir Andrew Witty

02 December 2010

Eddie Gray, President GSK Pharma Europe, speaks at FT pharmaceutical conference

The 27th annual FT Global Pharmaceutical & Biotechnology Conference took place in London on 1–2 December 2010. The event brought together thought-leaders from the pharmaceutical industry, patient groups, regulators, health technology assessment (HTA) groups to share insights and discuss the future for healthcare and the role of the pharmaceutical industry.

01 December 2010

CLSA China Conference

Mark Reilly, GM, Pharmaceuticals China & Hong Kong, gave a presentation at the CLSA China Conference on December 1 in New York City. Mark gave an update on GSK’s strategy and progress in its pharmaceuticals business in China.

22 November 2010

CEO Andrew Witty featured in The World in 2011

In The World in 2011, published in November 2010 by The Economist, Andrew Witty, CEO of GlaxoSmithKline, calls on the pharmaceutical industry to do more with less—and still be innovative.

Sir Andrew Witty